featured
Safety of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
Br J Dermatol 2022 Sep 09;[EPub Ahead of Print], EL Simpson, JF Merola, JI Silverberg, K Reich, RB Warren, D Staumont-Sallé, G Girolomoni, K Papp, M de Bruin-Weller, JP Thyssen, R Zachariae, CK Olsen, A WollenbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.